Table 1.

Clinical features of 19 patients with GCA and lower extremity (LE) vasculitis.

PatientSexAge, yrsNew HAJaw ClaudicationPMRESRTABLE StudyCV Risk FactorsTreatmentLE Surgery
1F58++59*+DopplerHTNGC
2F5835*NDAngioNoneGC
3F6235+AngioLipid PSGC, CYC, MTX
4F63+++110+MRAHTN, LipidGC, AZA
5F64++76+AngioNoneGC
6F6680NDAngioNoneGC+
7F66+++40+AngioHTNGC
8F68+45+AngioLipid, PSGC, AZA+
9F69++NA+AngioHTN, PSGC
10F70++102+AngioHTN, PSGC, AZA
11F70++31+AngioHTN, Lipid, PSGC, AZA+
12F71+++35+AngioNoneGC+
13F7351CTAHTN, LipidGC
14F74+33+DopplerNoneGC
15F74103NDCTAHTN, LipidGC+
16F76++57+AngioNoneGC
17F77+++60*AngioNoneGC
18F78++13*NDDopplerHTNGC
19F92+20*+AngioLipidGC+
  • * Patient was taking ≥ 5 mg prednisone. HA: headache; PMR: polymyalgia rheumatica; ESR: erythrocyte sedimentation rate; TAB: temporal artery biopsy; CV: cardiovascular; +: present; –: absent; NA: not available; ND: not done; angio: conventional angiogram; CTA: computed tomography angiography; MRA: magnetic resonance angiography; HTN: hypertension; PS: prior smoker; GC: glucocorticoid; AZA: azathioprine; MTX: methotrexate; CYC: cyclophosphamide.